EIF2AK4 mutation in pulmonary veno-occlusive disease: A case report and review of the literature

about

A case report of PVOD patient combined with pulmonary embolism: Anticoagulation or not?

P2860

Q37737318-8302DB87-4AEC-4B8E-8C46-AB819E2B7DBD

P2860

EIF2AK4 mutation in pulmonary veno-occlusive disease: A case report and review of the literature

Item

http://www.wikidata.org/entity/Q37605963

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on September 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

EIF2AK4 mutation in pulmonary ...... t and review of the literature

@en

EIF2AK4 mutation in pulmonary ...... and review of the literature.

@nl

type

Item

label

EIF2AK4 mutation in pulmonary ...... t and review of the literature

@en

EIF2AK4 mutation in pulmonary ...... and review of the literature.

@nl

prefLabel

EIF2AK4 mutation in pulmonary ...... t and review of the literature

@en

EIF2AK4 mutation in pulmonary ...... and review of the literature.

@nl

P1476

EIF2AK4 mutation in pulmonary ...... t and review of the literature

@en

P2093

Guofeng Ma

http://www.w3.org/2001/XMLSchema#string

Kai Chen

http://www.w3.org/2001/XMLSchema#string

Kejing Ying

http://www.w3.org/2001/XMLSchema#string

Li Liang

http://www.w3.org/2001/XMLSchema#string

Ruifeng Zhang

http://www.w3.org/2001/XMLSchema#string

Xiaohong Wu

http://www.w3.org/2001/XMLSchema#string

Yangxiang Liu

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International

P2860

Antiviral effect of the mammalian translation initiation factor 2alpha kinase GCN2 against RNA viruses

Regulation of G(1) arrest and apoptosis in hypoxia by PERK and GCN2-mediated eIF2alpha phosphorylation.

Amino acid availability controls TRB3 transcription in liver through the GCN2/eIF2α/ATF4 pathway

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS):

The Gcn2 kinase as a cell cycle regulator.

EIF2AK4 mutations in pulmonary capillary hemangiomatosis.

Chemotherapy-induced pulmonary hypertension: role of alkylating agents.

Pulmonary veno-occlusive disease: a case series and new observations.

Amino acid limitation regulates the expression of genes involved in several specific biological processes through GCN2-dependent and GCN2-independent pathways.

Occupational exposure to organic solvents: a risk factor for pulmonary veno-occlusive disease.

P304

e5030

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

review article

P356

10.1097/MD.0000000000005030

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P5008

ScienceSource

P577

2016-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27684876

http://www.w3.org/2001/XMLSchema#string

P921

pulmonary venoocclusive disease

genetic variation

DNA

Anzim

P932

5265969

http://www.w3.org/2001/XMLSchema#string

EIF2AK4 mutation in pulmonary veno-occlusive disease: A case report and review of the literature

about

P2860

P2860

EIF2AK4 mutation in pulmonary veno-occlusive disease: A case report and review of the literature

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P407

P433

P478

P5008

P577

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P407

P433

P478

P5008

P577

P698

P921

P932